Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FREMANEZUMAB vs FRUQUINTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FREMANEZUMAB vs FRUQUINTINIB: Safety Overview

Metric FREMANEZUMAB FRUQUINTINIB
Total FAERS Reports 224 2,565
Deaths Reported 2 874
Death Rate 0.9% 34.1%
Hospitalizations 39 753
Average Patient Age 47.1 yrs 63.9 yrs
% Female Patients 88.8% 44.4%
FDA Approval Date N/A Nov 8, 2023
Manufacturer Teva Pharmaceuticals USA, Inc. Takeda Pharmaceuticals America, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status N/A Prescription